Vaccinex Inc

+0.04 (+2.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Vaccinex Inc Stock, NASDAQ:VCNX

1895 Mount Hope Avenue, Rochester, New York 14620
United States of America
Phone: +1.585.271.2700
Number of Employees: 39


Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The firm focuses in the development of pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma and Huntingtonâ??s disease. Its products pipeline includes SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in April 2001 and is headquartered in Rochester, NY.